Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes
Long-acting GLP-1RAs are synthetic peptide molecules with modifications which further improve their stability
Two-layer sustained-release microneedles encapsulating exenatide for type 2 diabetes treatment
Mov Disord 28(1):3140 Olanow CW, Stern MB, Sethi K (2009) The scientific and clinical basis for the treatment of Parkinson disease
US$ 27.97
US$ 27.34
US$ 25.49
US$ 21.15
US$ 26.82
US$ 24.09
US$ 29.11
US$ 20.07
